Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Masaru Narabayashi"'
Autor:
Noriko, Kishi, Yukinori, Matsuo, Takashi, Shintani, Masakazu, Ogura, Takamasa, Mitsuyoshi, Norio, Araki, Kota, Fujii, Setsuko, Okumura, Kiyoshi, Nakamatsu, Takahiro, Kishi, Tomoko, Atsuta, Takashi, Sakamoto, Shuji, Ohtsu, Tomohiro, Katagiri, Masaru, Narabayashi, Satsuki, Fujishiro, Yusuke, Iizuka, Hiroaki, Ozasa, Toyohiro, Hirai, Takashi, Mizowaki
Publikováno v:
Journal of Radiation Research. 64:142-153
Chemoradiotherapy followed by consolidation durvalumab (CCRT+D) improves survival in patients with stage III non-small-cell lung cancer (NSCLC). We compared recurrence patterns and survival in the CCRT+D and CCRT cohorts. We conducted a multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8e2c7d35d3c7813f9b81dec7169867
https://doi.org/10.1093/jrr/rrac057
https://doi.org/10.1093/jrr/rrac057
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::237226d3c1f261ce61ed342bd23a0b14
https://doi.org/10.7759/cureus.30344
https://doi.org/10.7759/cureus.30344
Autor:
Kenta Fukumoto, Kimiko Hirata, Masaru Narabayashi, Kazunori Tanaka, Nobutaka Mukumoto, Yuki Hanai, Tomohiro Kosuga, Shuji Ohtsu
Publikováno v:
Breast Cancer. 28:1154-1162
The deep inspiration breath hold (DIBH) technique is effective for heart dose reduction in patients with left-sided breast cancer. In deep breathing, some women breathe in thoracic respiration; and others, in abdominal respiration. This study evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763926e19591ce363ffce34e5a288bf3
https://doi.org/10.1007/s12282-021-01259-4
https://doi.org/10.1007/s12282-021-01259-4
Autor:
M. Sakamoto, Takamasa Mitsuyoshi, Tomoko Atsuta, Norio Araki, Yukinori Matsuo, Takashi Sakamoto, Takashi Shintani, Tomohiro Katagiri, Yuichi Ishida, Setsuko Okumura, Kiyoshi Nakamatsu, Satsuki Fujishiro, Young Hak Kim, Takashi Mizowaki, Noriko Kishi, Kota Fujii, Masaru Narabayashi, Masakazu Ogura, Takahiro Kishi
Publikováno v:
Clinical lung cancer. 22(5)
Introduction Data on the risk factors for symptomatic radiation pneumonitis (RP) in non–small-cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) and consolidation durvalumab are limited; we aimed to investigate these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ccd3f2b86209a4ba7fc8277f51bc980
https://pubmed.ncbi.nlm.nih.gov/33678582
https://pubmed.ncbi.nlm.nih.gov/33678582
Autor:
Nobuyuki Katakami, T. Yokota, M. Arai, Katsunori Shinozaki, Narikazu Boku, T. Murata, Masaru Narabayashi, Masakazu Tsutsumi, Y. Tada, Toshiyuki Harada
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 29(6)
The efficacy and safety of naldemedine (a peripherally acting µ-opioid receptor antagonist) for opioid-induced constipation (OIC) in subjects with cancer was demonstrated in the primary report of a phase III, double-blind study (COMPOSE-4) and its o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf87baf998913658d3f6b645ddf2eb11
https://pubmed.ncbi.nlm.nih.gov/32151367
https://pubmed.ncbi.nlm.nih.gov/32151367
Autor:
Masatsugu Arai, Toru Murata, Toshiyuki Harada, Masaru Narabayashi, Narikazu Boku, Takaaki Yokota, Yukio Tada, Nobuyuki Katakami, Masakazu Tsutsumi, Katsunori Shinozaki
Publikováno v:
Journal of Clinical Oncology. 35:3859-3866
Purpose Opioid-induced constipation (OIC) is a frequent and debilitating adverse effect (AE) of opioids—common analgesics for cancer pain. We investigated the efficacy and safety of a peripherally acting μ-opioid receptor antagonist, naldemedine (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af45b03b64661f26f3cd50045cc2293
https://doi.org/10.1200/jco.2017.73.0853
https://doi.org/10.1200/jco.2017.73.0853
Autor:
Narikazu Boku, Takaaki Yokota, Ken Nakata, Katsunori Shinozaki, Nobuyuki Katakami, Koji Oda, Masaru Narabayashi, Katsunori Tauchi, Yura Suzuki
Publikováno v:
Journal of Clinical Oncology. 35:1921-1928
Purpose This randomized, double-blind, multicenter study aimed to determine the dose of naldemedine, a peripherally-acting μ-opioid receptor antagonist, for future trials by comparing the efficacy and safety of three doses of naldemedine versus plac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4481d8b0eea8baf5f366c56e58471c0
https://doi.org/10.1200/jco.2016.70.8453
https://doi.org/10.1200/jco.2016.70.8453
Autor:
Shin-ichiro Masunaga, Hiroki Tanaka, Tsubasa Watanabe, Hiroyuki Michiue, Yosuke Nakagawa, Masaru Narabayashi, Yoshinori Sakurai, Minoru Suzuki, Koji Ono, Natsuko Kondo, Yuko Kinashi
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 21:108-112
Aim In this study, we investigated γH2AX foci as markers of DSBs in normal brain and brain tumor tissue in mouse after BNCT. Background Boron neutron capture therapy (BNCT) is a particle radiation therapy in combination of thermal neutron irradiatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0417d367694a7c3e347d3d6dc6ef3504
https://doi.org/10.1016/j.rpor.2014.10.005
https://doi.org/10.1016/j.rpor.2014.10.005
Autor:
Masaru Narabayashi, Hiroki Tanaka, Yoshinori Sakurai, Natsuko Kondo, Yuko Kinashi, Tsubasa Watanabe, Koji Ono, Shin-ichiro Masunaga, Yoshiaki Nakagawa, Minoru Suzuki, Takushi Takata, Akira Maruhashi, N. Fujimoto
Publikováno v:
Applied Radiation and Isotopes. 106:134-138
It is important that improvements are made to depth dose distribution in boron neutron capture therapy, because the neutrons do not reach the innermost regions of the human body. Here, we evaluated the dose distribution obtained using multiple-field
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3551492c874e878c34619ec9d3978c
https://doi.org/10.1016/j.apradiso.2015.07.041
https://doi.org/10.1016/j.apradiso.2015.07.041
Autor:
Shin-Ichi Miyatake, Yoshinori Sakurai, Hasegawa Masatoshi, Minoru Suzuki, Natsuko Kondo, Yuki Hirota, Hiroki Tanaka, Yosuke Nakagawa, Tsubasa Watanabe, Koji Ono, Yuko Kinashi, Masaru Narabayashi, Shin-ichiro Masunaga, Takeo Ohnishi
Publikováno v:
Radiation and Environmental Biophysics. 55:89-94
Boron neutron capture therapy (BNCT) is a particle radiation therapy that involves the use of a thermal or epithermal neutron beam in combination with a boron ((10)B)-containing compound that specifically accumulates in tumor. (10)B captures neutrons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ab49c0bf705ef2e3aea449ff0b9b67
https://doi.org/10.1007/s00411-015-0625-2
https://doi.org/10.1007/s00411-015-0625-2